Drug Side Effects
Search
CLEAR CELL ENDOMETRIAL CARCINOMA
CLEAR CELL ENDOMETRIAL CARCINOMA
was reported 18 times
CLEAR CELL ENDOMETRIAL CARCINOMA is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Interleukin-17A Antagonist [EPC]
2
0.0001
1
Provitamin D2 Compound [EPC]
1
0.0000
2
Sympathomimetic-like Agent [EPC]
1
0.0000
3
Interferon beta [EPC]
4
0.0000
4
Interleukin-12 Antagonist [EPC]
2
0.0000
5
Interleukin-23 Antagonist [EPC]
2
0.0000
6
Angiotensin Converting Enzyme Inhibitor [EPC]
2
0.0000
7
Aromatase Inhibitor [EPC]
1
0.0000
8
Calcium [EPC]
1
0.0000
9
beta-Adrenergic Blocker [EPC]
2
0.0000
10
Janus Kinase Inhibitor [EPC]
1
0.0000
11
Vitamin C [EPC]
2
0.0000
12
Mood Stabilizer [EPC]
1
0.0000
13
Folate Analog Metabolic Inhibitor [EPC]
2
0.0000
14
GLP-1 Receptor Agonist [EPC]
2
0.0000
15
Platinum-based Drug [EPC]
1
0.0000
16
Progestin [EPC]
1
0.0000
17
CD20-directed Cytolytic Antibody [EPC]
1
0.0000
18
Benzodiazepine [EPC]
2
0.0000
19
HMG-CoA Reductase Inhibitor [EPC]
1
0.0000
20
Thalidomide Analog [EPC]
1
0.0000
21
Kinase Inhibitor [EPC]
1
0.0000
22
Platelet Aggregation Inhibitor [EPC]
1
0.0000
23
Proton Pump Inhibitor [EPC]
1
0.0000
24
Nonsteroidal Anti-inflammatory Drug [EPC]
1
0.0000